Stay tuned and follow the latest developments and news in Molecular Oncology.
Genekor Medical S.A., in collaboration with Women for Oncology – W4O Hellas, announces its participation in the initiative “Genetic Testing for Breast Cancer” (Participation Code: GEN-BC25).
As part of this initiative, up to 150 breast cancer patients registered with W4O Hellas will have access to high-penetrance genetic testing, including the analysis of key genes associated with hereditary breast cancer, such as BRCA1, BRCA2, PALB2, and others.
Testing is performed through the patients’ treating Medical Oncologists, at a special rate of €150, until December 31st, 2025.
This initiative aims to promote prevention, early diagnosis, and personalized patient care in oncology.
For more information: w4ohellas@gmail.com